Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | Oxford Science Enterprises plc | Former 10% Owner | Buy | 200,000 | $3.20 | $640,000.00 | +4.2% | → |
| 2025-09-26 | RA CAPITAL MANAGEMENT, L.P. | - | Buy | 9,375,000 | $3.20 | $30,000,000.00 | +102.1% | → |
| 2025-05-30 | STRECK PAUL | EVP, Head of R&D | Buy | 8,375 | $1.24 | $10,393.38 | +43.1% | → |
| 2025-04-17 | McArthur James G | President and CEO | Buy | 10,000 | $1.36 | $13,550.00 | +9.6% | → |
| 2025-04-08 | McArthur James G | President and CEO | Buy | 41,500 | $1.15 | $47,725.00 | +66.5% | → |
| 2025-02-26 | DeLena Mary Beth | General Counsel | Sell | 1,432 | $1.68 | $2,405.76 | -47.7% | → |
| 2025-02-26 | Donnelly Noel | Chief Financial Officer | Sell | 1,527 | $1.68 | $2,565.36 | -47.7% | → |
| 2024-07-25 | Mellion Michelle L | Chief Medical Officer | Sale+OE | 7,772 | $18.06 | $140,360.37 | -100% | → |
| 2024-07-18 | Mellion Michelle L | Chief Medical Officer | Sale+OE | 12,625 | $18.20 | $229,804.04 | -100% | → |
| 2024-07-16 | Mellion Michelle L | Chief Medical Officer | Sale+OE | 9,189 | $18.02 | $165,578.22 | -100% | → |
| 2024-07-02 | Mellion Michelle L | Chief Medical Officer | Sale+OE | 912 | $18.01 | $16,428.22 | -100% | → |
| 2024-06-24 | Mellion Michelle L | Chief Medical Officer | Sale+OE | 9,260 | $18.19 | $168,427.36 | -100% | → |
| 2024-06-12 | Mellion Michelle L | Chief Medical Officer | Sale+OE | 1,586 | $18.06 | $28,636.68 | -100% | → |
| 2024-06-06 | Mellion Michelle L | SVP, Clinical Development | Sale+OE | 8,656 | $18.08 | $156,460.05 | -100% | → |
| 2024-05-17 | Svenstrup Niels | SVP, Chem. Mfg & Controls | Sell | 10,000 | $13.41 | $134,100.00 | -100% | → |
| 2024-02-09 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Buy | 2,557,593 | $10.64 | $27,212,789.52 | +38.6% | → |
| 2023-11-30 | McArthur James G | President and CEO | Buy | 1,694 | $4.17 | $7,055.51 | New | → |
| 2023-06-08 | McArthur James G | President and CEO | Sale+OE | 2,381 | $16.04 | $38,187.91 | -100% | → |
| 2023-06-07 | McArthur James G | President and CEO | Sale+OE | 26,569 | $16.19 | $430,277.38 | -100% | → |
| 2023-06-05 | McArthur James G | President and CEO | Sale+OE | 2,300 | $16.04 | $36,891.00 | -100% | → |
| 2023-03-24 | Goyal Jaya | EVP, Res. & Preclin. Dev. | Sale+OE | 392 | $20.00 | $7,840.00 | -100% | → |
| 2023-02-08 | Goyal Jaya | EVP, Res. & Preclin. Dev. | Sale+OE | 6,000 | $17.12 | $102,728.27 | -100% | → |
| 2022-05-10 | RA CAPITAL MANAGEMENT, L.P. | - | Buy | 3,229,200 | $12.00 | $38,750,400.00 | +68.8% | → |
| 2022-05-10 | Flynn James E | - | Buy | 416,666 | $12.00 | $4,999,992.00 | +77.6% | → |
| 2022-05-06 | KEATING LAURIE | Director | Buy | 4,166 | $12.00 | $49,992.00 | New | → |